Skip to main content
. 2024 Dec 27;17:3033–3044. doi: 10.2147/CCID.S498987

Figure 6.

Figure 6

RXI-231-treated MelanoDerm tissues were assessed for TYR expression and melanin content. Treatment with RXI-231 results in a reduction in TYR mRNA of ~80% (A) and melanin content by ~40% (B). ****p<0.0001, **p<0.01.